Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2012 Oct 12;21(12):2159–2166. doi: 10.1158/1055-9965.EPI-12-0910

Table 1.

Male and Female Leukemia Cases in the SEER 13 and 18 Registries Databases, 1992 – 2009.

Sex Leukemia Type* No. of Cases** Age-Standardized Rate per 100,000 Person-Years (SD) Net Drift, percent per year 95% Confidence Interval (low, high)
Male AML 17,394 5.85 (0.04) +0.04 (−0.36, +0.43)
ALL 3,185 0.96 (0.02) +0.65 (−0.16, +1.48)
CML 8,922 2.93 (0.03) −1.03 (−1.52, −0.52)
CLL 23,819 10.05 (0.07) −0.98 (−1.35, −0.61)
Combined 53,320 17.8 (0.09) −0.36 (−0.59, −0.14)
Female AML 14,296 3.95 (0.03) +0.14 (−0.29, +0.58)
ALL 2,627 0.73 (0.01) +2.54 (+1.53, +3.56)
CML 6,115 1.69 (0.02) −0.95 (−1.59, −0.31)
CLL 15,090 5.13 (0.04) −0.55 (−1.05, −0.05)
Combined 38,128 10.5 (0.06) +0.05 (−0.22, +0.32)
*

Leukemia types based on ICD-O-3 codes. AML: 9840, 9861, 9866, 9867, 9871–9874, 9895–9897, 9910, 9920; ALL: 9826, 9835–9837; CML: 9863, 9875, 9876, 9945, 9946; CLL: 9823

**

Leukemia as first primary cancer. Patients diagnosed at ages 25 – 84 years old during 1992 – 2009 in SEER catchment areas with 3.42×108 and 3.59×108 person-years of follow-up among males and females, respectively.

2000 US Standard Population [Census P25-1130]. Age-standardized rate and its standard deviation (SD) estimated using weighted least squares.

Calculated from age-period-cohort model.